Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?

To: flickerful who wrote (311)	12/22/1997 5:12:00 PM
From: 5,17,37,5,101,...	Respond to of 756

Profuse apologies for the error. 25,000...Andrews, not 2,500; and he has been director for a while. Jackson

To: flickerful who wrote (311)	12/22/1997 10:00:00 PM
From: harkenman	Read Replies (2) \| Respond to of 756

Ivax Adopts Shareholder Rights Plan With 15% Trigger Dow Jones Newswires (WSJ Online) interactive4.wsj.com MIAMI -- Ivax Corp. (IVX) adopted a shareholder rights plan with a 15% trigger. In a press release Monday, the company said it is not adopting the plan in response to any takeover attempts. Under the plan, shareholders receive one right for each Ivax common share held at the close of business Dec. 29. The rights become exercisable if a party accumulates 15% or more of its common shares or announces an offer that would result in a party owning 15% or more of the common shares. The rights will expire Dec. 19, 2007, unless redeemed earlier. Each right entitles shareholders to buy 0.5 Ivax common share for $22.50. Ivax is a holding company with units in research, development, manufacturing and marketing of generic and branded pharmaceuticals.